Szela Mary T Insider Trades

Insider Trading History

Track insider trading activity for Szela Mary T. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kura Oncology
Kura Oncology KURA
Director
Holding Value $363k 35,000 shares
Last Trade
Jun 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$307k 35,000 shares
$8.77
$10.38
Absci
Absci ABSI
Director
Holding Value $295k 39,800 shares
Last Trade
Jun 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$366k 49,900 shares
$7.34
$7.41
Absci
Absci ABSI
Director
Holding Value $246k 33,200 shares
Last Trade
Jun 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$305k 41,600 shares
$7.34
$7.41
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
CEO And President
Holding Value $12.1M 1,065,215 shares
Last Trade
May 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$450k 39,682 shares
$11.35
$11.35
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
CEO And President
Holding Value $232k 1,065,215 shares
Last Trade
May 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.65k 39,682 shares
$0.22
$0.22
TriSalus Life Sciences
TriSalus Life Sciences TLSI
CEO And President
Holding Value $4.29M 1,065,215 shares
Last Trade
May 15, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$103k 39,682 shares
$2.59
$4.03
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
CEO And President
Holding Value $8.55M 752,987 shares
Last Trade
Mar 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$181k 15,944 shares
$11.35
$11.35
TriSalus Life Sciences
TriSalus Life Sciences TLSI
CEO And President
Holding Value $3.03M 752,987 shares
Last Trade
Mar 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$61.4k 15,944 shares
$3.85
$4.03
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
CEO And President
Holding Value $164k 752,987 shares
Last Trade
Mar 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.48k 15,944 shares
$0.22
$0.22
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
CEO And President
Holding Value $168k 768,931 shares
Last Trade
Mar 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$950 4,358 shares
$0.22
$0.22
TriSalus Life Sciences
TriSalus Life Sciences TLSI
CEO And President
Holding Value $3.1M 768,931 shares
Last Trade
Mar 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$18k 4,358 shares
$4.13
$4.03
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
CEO And President
Holding Value $8.73M 768,931 shares
Last Trade
Mar 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$49.5k 4,358 shares
$11.35
$11.35
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
CEO And President
Holding Value $169k 773,289 shares
Last Trade
Feb 23, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.65k 30,487 shares
$0.22
$0.22
TriSalus Life Sciences
TriSalus Life Sciences TLSI
CEO And President
Holding Value $3.12M 773,289 shares
Last Trade
Feb 23, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$152k 30,487 shares
$4.99
$4.03
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
CEO And President
Holding Value $8.78M 773,289 shares
Last Trade
Feb 23, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$346k 30,487 shares
$11.35
$11.35
TriSalus Life Sciences
TriSalus Life Sciences TLSI
CEO And President
Holding Value $6.36M 1,578,182 shares
Last Trade
Nov 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.75M 675,000 shares
$5.55
$4.03
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)
MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) MTACU
CEO And President
Holding Value $17.9M 1,578,182 shares
Last Trade
Nov 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.66M 675,000 shares
$11.35
$11.35
MedTech Acquisition - Warrants (18/12/2025)
MedTech Acquisition - Warrants (18/12/2025) MTACW
CEO And President
Holding Value $344k 1,578,182 shares
Last Trade
Nov 24, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$147k 675,000 shares
$0.22
$0.22
Absci
Absci ABSI
Director
Holding Value $1.32M 178,400 shares
Last Trade
Jul 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$460k 178,400 shares
$2.58
$7.41
Kura Oncology
Kura Oncology KURA
Director
Holding Value $296k 28,500 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$187k 28,500 shares
$6.57
$10.38

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up